A recent study examines the association between COVID-19 infection and an increased risk of recurrence in breast cancer ...
Phase III, Randomized, Double-Blind Study Comparing the Efficacy, Safety, and Immunogenicity of SB3 (Trastuzumab Biosimilar) and Reference Trastuzumab in Patients Treated With Neoadjuvant Therapy for ...
PTNB before surgery in stage 1 NSCLC patients is linked to higher local-regional recurrence and mortality rates. The study included 2026 patients, with 38.6% undergoing PTNB, showing higher recurrence ...
Please provide your email address to receive an email when new articles are posted on . Preoperative breast MRI provides no benefit in stage I or II hormone receptor-negative breast cancer. Five-year ...
MedPage Today on MSN
Low breast cancer recurrence rate with radiotherapy tailored to nodal response
Locoregional recurrence rate of 2.9% overall with no variation across node-defined risk gr ...
SAN ANTONIO -- Preoperative MRI for staging patients with early, hormone receptor (HR)-negative breast cancer didn't result in improved oncologic outcomes or improved clinical care, according to a ...
Breast cancer remains a major global health challenge, with more than 2.3 million new cases annually. To address this, international guidelines, such as those from the National Comprehensive Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results